Hypotension to central endothelin-1: effect of glutamate receptor blockade

Biochem Biophys Res Commun. 1994 Nov 30;205(1):795-801. doi: 10.1006/bbrc.1994.2735.

Abstract

Endothelin-1 (ET-1) produces hypotension via an action at glutamate-sensitive medullary cardiovascular sites. Here, we used excitatory amino acid (EAA) receptor antagonists to examine the possible role of an endogenous EAA in this neural action of central ET-1. ET-1 (3 pmol) applied to the IV ventricle of anesthetized, artificially ventilated rats elicited a sustained decrease in blood pressure (27 +/- 6%). Pretreatment with two EAA receptor antagonists, APV and CNQX (or MK-801 and CNQX), significantly attenuated the hypotension to central ET-1 (11 +/- 4%). Since these antagonists do not interact with endothelin receptors, we conclude that release of an endogenous EAA may contribute to the hypotensive action of central ET-1.

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Dizocilpine Maleate / pharmacology
  • Endothelins / administration & dosage
  • Endothelins / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Hypotension*
  • Infusions, Intravenous
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glutamate / metabolism*

Substances

  • Endothelins
  • Excitatory Amino Acid Antagonists
  • Receptors, Glutamate
  • Dizocilpine Maleate
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 2-Amino-5-phosphonovalerate